Zobrazeno 1 - 10
of 145
pro vyhledávání: '"low drug dose"'
Publikováno v:
Journal of Medical Case Reports, Vol 13, Iss 1, Pp 1-8 (2019)
Journal of Medical Case Reports
Journal of Medical Case Reports
Background In clinical practice, identification of a case of severe asthma exacerbation prompts initiation of corticosteroids. However, not all that wheezes is asthma. Case presentation A 61-year-old man from the Peruvian Amazon presented with progre
Watanabe and Tatsuno [1] in their state-of-the-art review on omega-3 fatty acids for the prevention of cardiovascular diseases commented that the effects of omega-3 fatty acids on the risk of atria...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::917385af9babbe153dfcdf49725a4653
https://hdl.handle.net/10576/29971
https://hdl.handle.net/10576/29971
Autor:
Aliihsan Gemici, Senem Maral, Fahir Özkalemkaş, Huseyin Saffet Bekoz, Eren Gunduz, Rafet Eren, Mehmet Hilmi Dogu, İbrahim Ethem Pinar, Istemi Serin, Ahmet Kursad Gunes, Gulsum Akgun Cagliyan, Volkan Karakuş, Inci Alacacioglu, Fatma Deniz Sargın, Atakan Tekinalp, Idris Ince, Ömür Gökmen Sevindik, Tekin Guney, Ayfer Gedük
Venetoclax is a selective B-cell lymphoma 2 (BCL2) inhibitor, which is approved to treat elderly patients with newly diagnosed acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). A total of 60 patients with a median age of 67 y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4060a764721dba18c867b26d59f71f3b
https://hdl.handle.net/20.500.12511/7984
https://hdl.handle.net/20.500.12511/7984
Autor:
Eva Hansvenclova, Jurriën M. ten Berg, Robert Cooper, Maciej Dabrowski, Maksim Kashtanov, Lothar Faber, Rodney H. Stables, Jiri Jarkovsky, Morten Kvistholm Jensen, Max Liebregts, Eva Polakova, Hubert Seggewiss, Peter Riis Hansen, Jaroslav Januška, Henning Bundgaard, Jiri Bonaventura, Josef Veselka
Publikováno v:
Veselka, J, Faber, L, Liebregts, M, Cooper, R, Januska, J, Kashtanov, M, Dabrowski, M, Hansen, P R, Seggewiss, H, Bonaventura, J, Polakova, E, Hansvenclova, E, Bundgaard, H, ten Berg, J, Stables, R H, Jarkovsky, J & Jensen, M K 2021, ' Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy ', International Journal of Cardiology, vol. 333, pp. 127-132 . https://doi.org/10.1016/j.ijcard.2021.02.056
Int. J. Cardiol.
International Journal of Cardiology
Veselka, J, Faber, L, Liebregts, M, Cooper, R, Januska, J, Kashtanov, M, Dabrowski, M, Hansen, P R, Seggewiss, H, Bonaventura, J, Polakova, E, Hansvenclova, E, Bundgaard, H, Ten Berg, J, Stables, R H, Jarkovsky, J & Jensen, M K 2021, ' Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy ', International Journal of Cardiology, vol. 333, pp. 127-132 . https://doi.org/10.1016/j.ijcard.2021.02.056
Int. J. Cardiol.
International Journal of Cardiology
Veselka, J, Faber, L, Liebregts, M, Cooper, R, Januska, J, Kashtanov, M, Dabrowski, M, Hansen, P R, Seggewiss, H, Bonaventura, J, Polakova, E, Hansvenclova, E, Bundgaard, H, Ten Berg, J, Stables, R H, Jarkovsky, J & Jensen, M K 2021, ' Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy ', International Journal of Cardiology, vol. 333, pp. 127-132 . https://doi.org/10.1016/j.ijcard.2021.02.056
BACKGROUND: The aim of this study was to evaluate short- and long-term outcomes related to dose of alcohol administered during alcohol septal ablation (ASA) in patients with hypertrophic obstructive cardiomyopathy (HOCM). Current guidelines recommend
Autor:
Marieke T. Blom, Anthonius de Boer, Arie O. Verkerk, Patrick C. Souverein, Fredrik Folke, Hanno L. Tan, G H Mohr, Talip E Eroglu, Richard P. Davis, Mads Wissenberg, Lettine van den Brink, Gunnar Gislason, Christian Torp-Pedersen
Publikováno v:
Eroglu, T E, Mohr, G H, Blom, M T, Verkerk, A O, Souverein, P C, Torp-Pedersen, C, Folke, F, Wissenberg, M, Van Den Brink, L, Davis, R P, De Boer, A, Gislason, G H & Tan, H L 2020, ' Differential effects on out-of-hospital cardiac arrest of dihydropyridines : real-world data from population-based cohorts across two European countries ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 6, no. 6, pp. 347-355 . https://doi.org/10.1093/ehjcvp/pvz038
Eroglu, T E, Mohr, G H, Blom, M T, Verkerk, A O, Souverein, P C, Torp-Pedersen, C, Folke, F, Wissenberg, M, van den Brink, L, Davis, R P, de Boer, A, Gislason, G H & Tan, H L 2020, ' Differential effects on out-of-hospital cardiac arrest of dihydropyridines : real-world data from population-based cohorts across two European countries ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 6, no. 6, pp. 347-355 . https://doi.org/10.1093/ehjcvp/pvz038
European Heart Journal-Cardiovascular Pharmacotherapy, 6(6), 347-355. OXFORD UNIV PRESS
European Heart Journal-Cardiovascular Pharmacotherapy, 6(6), 347-355. Oxford University Press
Eroglu, T E, Mohr, G H, Blom, M T, Verkerk, A O, Souverein, P C, Torp-Pedersen, C, Folke, F, Wissenberg, M, van den Brink, L, Davis, R P, de Boer, A, Gislason, G H, Tan, H L & ESCAPE-NET Investigators 2020, ' Differential effects on out-of-hospital cardiac arrest of dihydropyridines : real-world data from population-based cohorts across two European countries ', European heart journal. Cardiovascular pharmacotherapy, vol. 6, no. 6, pp. 347–355 . https://doi.org/10.1093/ehjcvp/pvz038
European Heart Journal — Cardiovascular Pharmacotherapy
European heart journal. Cardiovascular pharmacotherapy, 6, 347. NLM (Medline)
European heart journal. Cardiovascular pharmacotherapy, 6(6), 347-355. Oxford University Press
European Heart Journal-Cardiovascular Pharmacotherapy
Eroglu, T E, Mohr, G H, Blom, M T, Verkerk, A O, Souverein, P C, Torp-Pedersen, C, Folke, F, Wissenberg, M, van den Brink, L, Davis, R P, de Boer, A, Gislason, G H & Tan, H L 2020, ' Differential effects on out-of-hospital cardiac arrest of dihydropyridines : real-world data from population-based cohorts across two European countries ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 6, no. 6, pp. 347-355 . https://doi.org/10.1093/ehjcvp/pvz038
European Heart Journal-Cardiovascular Pharmacotherapy, 6(6), 347-355. OXFORD UNIV PRESS
European Heart Journal-Cardiovascular Pharmacotherapy, 6(6), 347-355. Oxford University Press
Eroglu, T E, Mohr, G H, Blom, M T, Verkerk, A O, Souverein, P C, Torp-Pedersen, C, Folke, F, Wissenberg, M, van den Brink, L, Davis, R P, de Boer, A, Gislason, G H, Tan, H L & ESCAPE-NET Investigators 2020, ' Differential effects on out-of-hospital cardiac arrest of dihydropyridines : real-world data from population-based cohorts across two European countries ', European heart journal. Cardiovascular pharmacotherapy, vol. 6, no. 6, pp. 347–355 . https://doi.org/10.1093/ehjcvp/pvz038
European Heart Journal — Cardiovascular Pharmacotherapy
European heart journal. Cardiovascular pharmacotherapy, 6, 347. NLM (Medline)
European heart journal. Cardiovascular pharmacotherapy, 6(6), 347-355. Oxford University Press
European Heart Journal-Cardiovascular Pharmacotherapy
Aims Various drugs increase the risk of out-of-hospital cardiac arrest (OHCA) in the general population by impacting cardiac ion channels, thereby causing ventricular tachycardia/fibrillation (VT/VF). Dihydropyridines block L-type calcium channels, b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68d0a97c7c98f3435f87e98e56994766
https://research.vumc.nl/en/publications/d71dfada-692e-42f4-811e-6a88f730517a
https://research.vumc.nl/en/publications/d71dfada-692e-42f4-811e-6a88f730517a
Autor:
Torsten Blum, Francesco Bonella, Paolo Spagnolo, Demosthenes Bouros, Daniel A. Culver, Katerina M. Antoniou, Venerino Poletti, Jacques Cadranel, Ganesh Raghu, Theodoros Karampitsakos, Athol U. Wells, Carlo Vancheri, Stefano Elia, Matthew Evison, Maria Molina-Molina, Elisabeth Bendstrup, Argyris Tzouvelekis, Bogdan Grigoriu, Nesrin Mogulkoc, Michael Kreuter
Publikováno v:
ERJ Open Research
ERJ Open Research, European Respiratory Society, 2021, 7 (1), pp.00529-2020. ⟨10.1183/23120541.00529-2020⟩
article-version (VoR) Version of Record
Dipòsit Digital de la UB
Universidad de Barcelona
ERJ Open Research, Vol 7, Iss 1 (2021)
ERJ Open Research, European Respiratory Society, 2021, 7 (1), pp.00529-2020. ⟨10.1183/23120541.00529-2020⟩
article-version (VoR) Version of Record
Dipòsit Digital de la UB
Universidad de Barcelona
ERJ Open Research, Vol 7, Iss 1 (2021)
Background Currently there is major lack of agreement on the diagnostic and therapeutic management of patients with idiopathic pulmonary fibrosis (IPF) and lung cancer. Our aim was to identify variations in diagnostic and management strategies across
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbbfa1a99ec72571cb8c2c67f1aa607d
http://hdl.handle.net/2445/176217
http://hdl.handle.net/2445/176217
Autor:
Akbudak, İsmail Hakkı
Corticosteroid therapy has been used for many years and is still controversial in use. In the Coronovirus disease 2019 (COVID-19) outbreak, it is very important to find reliable treatment information for clinicians and patients. Low dose corticostero
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::b8ee7a542c699c6f2e91b61661bef259
Autor:
Saliha Ayşenur Çam, Muhammed Fatih Dogan, Ali Parlar, Seyfullah Oktay Arslan, Fatma Uysal, Elif Merve Tosun
Asthma is an inflammatory disease of the airways of the lungs, which is characterized by airflow obstruction and bronchospasms. Glabridin is a major flavonoid, especially found in root of Glycyrrhiza glabra, and has several pharmacological activities
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79ac9983ea8a657c35195a9835ce6074
Autor:
Emilie M Gieling, Anthonius de Boer, Rachel G. Williams, Hein A W van Onzenoort, Cornelis Kramers, Vincent ten Cate, Andrea M. Burden, Frank de Vries
Publikováno v:
International Journal of Clinical Pharmacy, 41 (6)
International Journal of Clinical Pharmacy, 41, 1536-1544
International Journal of Clinical Pharmacy, 41, 6, pp. 1536-1544
International Journal of Clinical Pharmacy, 2019(41). Springer
International Journal of Clinical Pharmacy, 41(6), 1536. Springer Netherlands
International Journal of Clinical Pharmacy, 41(6), 1536-1544. Springer, Cham
International Journal of Clinical Pharmacy, 41, 1536-1544
International Journal of Clinical Pharmacy, 41, 6, pp. 1536-1544
International Journal of Clinical Pharmacy, 2019(41). Springer
International Journal of Clinical Pharmacy, 41(6), 1536. Springer Netherlands
International Journal of Clinical Pharmacy, 41(6), 1536-1544. Springer, Cham
Background As an alternative to vitamin K antagonist and low-dose aspirin ( 2). Conclusion Non vitamin K oral anticoagulants are associated with a higher risk on all-cause mortality, particularly in men and in patients with higher stroke risk.
I
I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::932f5765f851dba8d5d2c8ab70671a41
https://hdl.handle.net/20.500.11850/385382
https://hdl.handle.net/20.500.11850/385382
Publikováno v:
Pharmaceutisch Weekblad. 153(48):14-16